#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Lymphoma Cardiac failure acute Waldenstrom's macroglobulinaemia refractory Microscopic polyangiitis Enteritis Oesophageal adenocarcinoma Pulmonary tuberculosis Haemophilia A without inhibitors Myocarditis Immune-mediated myasthenia gravis Autoimmune hepatitis White matter lesion Central nervous system neoplasm IPEX syndrome Breast angiosarcoma More trials…
Learn about Rare Diseases

Combined immunodeficiency – Life with Disease Erdheim-Chester disease – Trials in Disease Synovial sarcoma recurrent – Treatment Medulloblastoma – Trials in Disease Mantle cell lymphoma stage II – Diagnostics Usher’s syndrome Prolymphocytic leukaemia – Basic Information Hereditary optic atrophy – Treatment Hairy cell leukaemia – Treatment Waldenstrom’s macroglobulinaemia refractory More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

TTX-381 Tropicamide Navtemadlin Ranitidine Dazostinag Gindameran Imifoplatin MZE829 Ligelizumab Avatrombopag Canakinumab APROTININ Gsk4527226 Selexipag Tapderimotide SODIUM SELENITE PENTAHYDRATE Levamisole Hydrochloride Fedratinib Ezetimibe AZD3632 More therapies…

Learn about Your Condition

Skin candida Tumour of ampulla of Vater Pelvic venous thrombosis Deafness bilateral Hepatobiliary cancer Acute HIV infection Cerebellar ataxia Heparin resistance Neuroendocrine carcinoma Death neonatal Infantile spasms Parkinson's disease Albuminuria Reperfusion injury Subdural haematoma More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Niemann-Pick disease

A Study to Evaluate the Safety of Olipudase Alfa in Children and Adults with Niemann-Pick Disease Who Completed Previous Treatment Studies

Not recruiting

2 1 1
Investigated Diseases:
- Niemann-Pick disease
Study on the Safety and Long-Term Effects of Efavirenz for Adults and Late-Onset Juvenile Niemann-Pick Type C Disease with Cognitive Impairment

Not recruiting

2 1 1 1
Investigated Diseases:
- Niemann-Pick disease
Investigated Drugs:
- Aprepitant
Study on the Safety and Effectiveness of Hydroxypropylbetadex and Miglustat for Patients with Niemann-Pick Disease Type C1

Not recruiting

3 1 1
Investigated Diseases:
- Niemann-Pick disease
Investigated Drugs:
- Hydroxypropylbetadex
- Miglustat

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Niemann-Pick disease

A Study to Evaluate the Safety of Olipudase Alfa in Children and Adults with Niemann-Pick Disease Who Completed Previous Treatment Studies

Study on the Safety and Long-Term Effects of Efavirenz for Adults and Late-Onset Juvenile Niemann-Pick Type C Disease with Cognitive Impairment

Study on the Safety and Effectiveness of Hydroxypropylbetadex and Miglustat for Patients with Niemann-Pick Disease Type C1

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies